» Articles » PMID: 30305610

Degranulation of Mast Cells Induced by Gastric Cancer-derived Adrenomedullin Prompts Gastric Cancer Progression

Abstract

Mast cells are prominent components of solid tumors and exhibit distinct phenotypes in different tumor microenvironments. However, their precise mechanism of communication in gastric cancer remains largely unclear. Here, we found that patients with GC showed a significantly higher mast cell infiltration in tumors. Mast cell levels increased with tumor progression and independently predicted reduced overall survival. Tumor-derived adrenomedullin (ADM) induced mast cell degranulation via PI3K-AKT signaling pathway, which effectively promoted the proliferation and inhibited the apoptosis of GC cells in vitro and contributed to the growth and progression of GC tumors in vivo, and the effect could be reversed by blocking interleukin (IL)-17A production from these mast cells. Our results illuminate a novel protumorigenic role and associated mechanism of mast cells in GC, and also provide functional evidence for these mast cells to prevent, and to treat this immunopathogenesis feature of GC.

Citing Articles

Pro-Tumorigenic Effect of Continuous Cromolyn Treatment in Bladder Cancer.

Frankovic L, Degoricija M, Gabela I, Vilovic K, Korac-Prlic J Int J Mol Sci. 2025; 26(4).

PMID: 40004083 PMC: 11855506. DOI: 10.3390/ijms26041619.


Mast cells: key players in digestive system tumors and their interactions with immune cells.

Shu F, Yu J, Liu Y, Wang F, Gou G, Wen M Cell Death Discov. 2025; 11(1):8.

PMID: 39814702 PMC: 11735678. DOI: 10.1038/s41420-024-02258-y.


The regulatory role and mechanism of mast cells in tumor microenvironment.

Ligan C, Ma X, Zhao S, Zhao W Am J Cancer Res. 2024; 14(1):1-15.

PMID: 38323271 PMC: 10839313.


An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma.

Yang C, Cao F, He Y Med Sci Monit. 2023; 29:e940157.

PMID: 37632137 PMC: 10467311. DOI: 10.12659/MSM.940157.


Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.

Liu X, Li X, Wei H, Liu Y, Li N Front Immunol. 2023; 14:1209056.

PMID: 37497234 PMC: 10366593. DOI: 10.3389/fimmu.2023.1209056.


References
1.
Johnson C, Huynh V, Hargrove L, Kennedy L, Graf-Eaton A, Owens J . Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling. Am J Pathol. 2015; 186(1):123-33. PMC: 5707204. DOI: 10.1016/j.ajpath.2015.09.016. View

2.
Melillo R, Guarino V, Avilla E, Galdiero M, Liotti F, Prevete N . Mast cells have a protumorigenic role in human thyroid cancer. Oncogene. 2010; 29(47):6203-15. DOI: 10.1038/onc.2010.348. View

3.
Moller Westerberg C, Hagglund H, Nilsson G . Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation. Cell Death Dis. 2012; 3:e417. PMC: 3542593. DOI: 10.1038/cddis.2012.157. View

4.
Vonderheide R . Tumor-promoting inflammatory networks in pancreatic neoplasia: another reason to loathe Kras. Cancer Cell. 2014; 25(5):553-4. PMC: 4077610. DOI: 10.1016/j.ccr.2014.04.020. View

5.
Marichal T, Tsai M, Galli S . Mast cells: potential positive and negative roles in tumor biology. Cancer Immunol Res. 2014; 1(5):269-79. DOI: 10.1158/2326-6066.CIR-13-0119. View